Alurar rigakafin Hepatitis A da B ta hadin gwiwa (Twinrix®) alura ce da ke ba da kariya daga cututtukan hanta guda biyu — Hepatitis A da Hepatitis B — a allura guda daya maimakon allura biyu daban-daban. Wannan ya sa jadawalin ya fi sauki da sauƙi. A Nijeriya, duka Hepatitis A da B suna yaduwa sosai. Hepatitis B musamman babbar matsala ce — Nijeriya tana cikin kasashen da suka fi fama da cutar a duniya. Hepatitis A ma ta yadu musamman a yankunan da ba su da isassun kayan tsafta. Twinrix® na da
Alurar rigakafin Hepatitis A da B ta hadin gwiwa (Twinrix®) alura ce da ke ba da kariya daga cututtukan hanta guda biyu — Hepatitis A da Hepatitis B — a allura guda daya maimakon allura biyu daban-daban. Wannan ya sa jadawalin ya fi sauki da sauƙi.
A Nijeriya, duka Hepatitis A da B suna yaduwa sosai. Hepatitis B musamman babbar matsala ce — Nijeriya tana cikin kasashen da suka fi fama da cutar a duniya. Hepatitis A ma ta yadu musamman a yankunan da ba su da isassun kayan tsafta.
Twinrix® na dauke da inactivated Hepatitis A virus da recombinant HBsAg (Hepatitis B surface antigen). NAFDAC ta amince da ita don amfani a Nijeriya.
Wadanda ya kamata su samu alurar Hepatitis A+B combo:
Matafiya: Duk wanda ke tafiya zuwa yankunan da Hepatitis A da B ke yaduwa — wannan ya hada da kusan duk kasashen Afirka da Asiya.
Ma'aikatan kiwon lafiya: Wadanda ke mu'amala da jini da marasa lafiya — suna bukatar kariya daga Hepatitis B musamman.
Mutane masu yawan tafiya: Sojojin, ma'aikatan agaji, ma'aikatan jirgin ruwa.
Mutane masu cutar hanta ta daban: Masu Hepatitis C, masu cutar hanta na barasa.
Manya da ba su da kariya: Wadanda ba su samu wani alurar Hepatitis A ko B ba.
A Nijeriya:
Yawancin yara sun riga sun samu alurar Hepatitis B ta hanyar pentavalent a NPI
Twinrix® na iya zama mai amfani ga manya da ba su samu alurar Hepatitis B a yara ba
Ana samun ta a wasu asibitocin masu zaman kansu
Ba a ba da alurar Hepatitis A+B combo ga wadannan mutane ba:
Matsanancin rashin lafiyar abubuwan da ke cikin allurar: Musamman rashin lafiyar neomycin, yeast, ko formaldehyde.
Anaphylaxis bayan shan Hepatitis A ko B da ta gabata.
Yara kasa da shekara 1: Ba a amince da Twinrix® ga wannan shekarun ba.
Rashin lafiya mai tsanani tare da zazzabi: Sai a jinkirta.
Ba a hana ba da ita ga:
Mata masu juna biyu — ana ba da shawarar idan suna cikin hadari
Masi shayar da nono
Masu HIV
Mutane masu raunin garkuwar jiki (amma ingancin na iya raguwa)
Sakamako na alurar Hepatitis A+B combo (Twinrix®):
Sakamako na yau da kullum (30-50%):
Zafin wurin allura (35-45%)
Ciwon kai (15-25%)
Gajiya (10-18%)
Ciwon tsokoki (8-12%)
Dan zazzabi (5-8%)
Tashin zuciya (3-5%)
Wadannan suna warwarewa cikin kwanaki 1-3.
Sakamako masi tsanani: Da wuya sosai — kamar yadda yake ga kowane daga cikin allurar Hepatitis A da B daban-daban.
Bayani: Sakamako na Twinrix® kusan daidai suke da na allurar Hepatitis A da B da aka ba su daban-daban.
Yadda ake ba da alurar Hepatitis A+B combo (Twinrix®):
Jadawali na yau da kullum:
Allura 3: Watanni 0, 1, da 6
1.0 mL ga manya (shekaru 16+)
IM injection (deltoid)
Jadawalin gaggawa (accelerated):
Allura 4: Kwanaki 0, 7, 21 + booster a wata 12
Wannan ya dace ga matafiya da ba su da lokaci
Ajiye alurar: 2-8°C. Kada a daskare.
Samuwar a Nijeriya: Ana samun Twinrix® a wasu asibitocin masi zaman kansu da kantin magunguna a manyan birane. Farashin na iya zama mai tsada ga mutane da yawa.
Ingancin alurar Hepatitis A+B combo:
Bayan cikakken jadawali (allura 3):
Hepatitis A: 99-100% kariya
Hepatitis B: 95-99% kariya (anti-HBs ≥10 mIU/mL)
Kwatanta da allurar daban-daban:
Ingancin Twinrix® kusan daidai yake da yadda za a samu idan an ba da allurar Hepatitis A da B daban-daban
Fa'idar Twinrix®: Allurar 3 maimakon 5 (2 na Hepatitis A + 3 na Hepatitis B = 5; ko 3 na Twinrix®)
Tsawon kariya:
Hepatitis A: Shekaru 25-40+ (yiwuwa tsawon rayuwa)
Hepatitis B: Shekaru 30+ tare da immune memory
Jadawalin gaggawa:
A Nijeriya:
Mu'amalar alurar Hepatitis A+B combo da wasu magunguna:
Wasu allurar: Ana iya ba da Twinrix® tare da yawancin allurar matafiya (Yellow Fever, Typhoid, Meningococcal, da sauransu) a wurare daban-daban.
Immunoglobulin: Ana iya ba da Hepatitis B Immune Globulin (HBIG) tare da Twinrix® a wurare daban-daban — amma Hepatitis A component na iya samun dan raguwar inganci.
Magunguna masi rage garkuwar jiki: Ingancin na iya raguwa — ana iya bukatar gwajin jini bayan kammala jadawalin.
Bayani: Twinrix® ya fi sauƙi ga matafiya saboda yana rage yawan allurar da ake bukata.
Pregnancy: Twinrix® (inactivated hepatitis A + recombinant hepatitis B) has limited data in pregnancy. Both individual components (hepatitis A and hepatitis B vaccines) have established safety profiles in pregnancy. Hepatitis B vaccination is routinely recommended for pregnant women at risk of HBV infection. Hepatitis A vaccine may be administered during pregnancy when indicated. The theoretical risk from inactivated vaccines during pregnancy is negligible. Consider Twinrix® if both hepatitis A and B protection are needed and the travel timeline is tight.
Breastfeeding: Twinrix® (inactivated) is compatible with breastfeeding. Both hepatitis A and hepatitis B vaccines are inactivated and pose no risk to the breastfed infant. Inactivated vaccines do not replicate and cannot be transmitted through breast milk. No modification of breastfeeding schedule is required. Vaccination of breastfeeding mothers who require hepatitis A and/or B protection should not be deferred.
Pediatric use: Twinrix® is approved for individuals ≥18 years in the United States. A pediatric/adolescent formulation (Twinrix Junior®) is available in some markets for children aged 1–15 years. For children under the approved age, individual hepatitis A and hepatitis B vaccines should be administered separately. Hepatitis A vaccine is recommended from 12 months of age; hepatitis B vaccine is given as part of the routine birth dose series. Children traveling internationally should ideally complete both vaccine series before travel.
Older adults (≥65 years): Twinrix® can be administered to older adults. Immune response to both hepatitis A and hepatitis B components may be diminished in older adults due to immunosenescence. For hepatitis B specifically, seroconversion rates decline with age (approximately 75% in adults ≥60 vs >95% in young adults). Post-vaccination serological testing (anti-HBs) may be considered for older adults at ongoing risk. A higher-dose hepatitis B vaccine (Heplisav-B®) may be used separately if enhanced HBV response is desired.
Matakan kariya:
Idan mutum ya riga ya samu daya daga cikin allurar:
Idan ya riga ya samu alurar Hepatitis A amma ba Hepatitis B ba (ko akasin haka), za a iya kammala jadawalin ta hanyar ba da allurar da ya rage daban-daban
Ba a bukatar sake fara jadawalin daga farko ba
Gwajin jini bayan allura:
A Nijeriya:
Yawancin manya ba su san ko suna dauke da Hepatitis B ba — ana ba da shawarar gwajin HBsAg kafin fara jadawalin allura
Idan mutum ya riga ya dauke da Hepatitis B, alurar ba za ta amfane shi ba — yana bukatar magani
NCDC na ci gaba da wayar da kan jama'a game da gwajin Hepatitis B
| Allura | Alama | Kwanaki daga na baya | Kewayon shekaru |
|---|---|---|---|
| Allura 1 | Twinrix | — | — |
| Allura 1 | Twinrix | — | — |
| Allura 1 | Twinrix | — | — |
| Allura 2 | Twinrix | 30d | — |
| Allura 2 | Twinrix | 7d | — |
| Allura 2 | Twinrix | 30d | — |
| Allura 3 | Twinrix | 150d | — |
| Allura 3 | Twinrix | 150d | — |
| Allura 3 | Twinrix | 14d | — |
| Allura 4 | Twinrix | 365d | — |
Kun san allurar rigakafin da kuke bukata? Da kyau. Ba ku sani ba? Ku gaya mana inda kuke tafiya — za mu nemo allurar da ta dace da asibiti. Kyauta, ba tare da wani hakki ba.
Abun ciki a wannan shafin don bayani da ilimi ne kawai. Ba ya zama shawarar likita, gano cuta, ko shawarwarin magani ba. Idan kuna da damuwar lafiya, tuntuɓi ƙwararren ma’aikacin lafiya. Medova ba mai ba da sabis na likitanci ba ne.
Cikakkun sharuɗɗan amfani